As of 2024, B/Victoria-lineage strains have emerged as the predominant influenza B viruses globally. To elucidate the antigenic regions responsible for variation within this lineage, three monoclonal antibodies (MAbs) targeting the hemagglutinin (HA) protein were employed to generate escape mutants of the B/Victoria strain B/Aichi/20/99, which was isolated approximately 10 years after the B/Victoria and B/Yamagata lineages began cocirculating. A total of 45 escape mutants were obtained. Sequencing of their HA genes identified six amino acid substitutions at four sites within two key antigenic regions—the 160-loop and 190-helix—specifically, N165Y, N165S, K167R, and an asparagine insertion between residues 164 and 165 in the 160-loop; and K203R and K203N in the 190-helix (numbering is based on the B/Brisbane/60/2008 HA sequence). Hemagglutination inhibition (HI) assays revealed that two MAbs affected binding of both mutants with mutations in the 160-loop and those with a mutation at residue 203. Mutations in the 160-loop did not affect reactivity with antiserum against the parental B/Aichi/20/99 strain, whereas K203N substitution reduced antiserum reactivity, indicating the antigenic importance of this residue. Further HI analyses using eight B/Victoria lineage strains isolated between 1997 and 2021 showed that all three MAbs lost reactivity with strains isolated after 2016, while the antiserum demonstrated reduced reactivity. Notably, the current vaccine strain, B/Austria/1359417/2021, which harbors substitutions at positions 150 and 203, also exhibited diminished reactivity. These findings suggest that both the 150-loop and 190-helix constitute antigenically dominant sites that contribute to immune escape and the emergence of drift variants within the B/Victoria-lineage.
扫码关注我们
求助内容:
应助结果提醒方式:
